Search results
Results from the WOW.Com Content Network
The Blalock–Thomas–Taussig shunt (BTT shunt), [1] previously known as the Blalock–Taussig Shunt (BT shunt), [2] is a surgical procedure used to increase blood flow to the lungs in some forms of congenital heart disease [3] such as pulmonary atresia and tetralogy of Fallot, which are common causes of blue baby syndrome. [3]
Eileen Saxon, sometimes referred to as "The Blue Baby", was the first patient that received the operation now known as Blalock–Thomas–Taussig shunt.. She had a condition called Tetralogy of Fallot, one of the primary congenital defects that lead to blue baby syndrome.
Doctors are warning patients not to wear spandex clothing when coming in for a magnetic resonance imaging (MRI) procedure. Fabrics that use spandex often have metallic threads that could react ...
The Mustard procedure was developed in 1963 by Dr. William Mustard at the Hospital for Sick Children.It is similar to the previous atrial baffle used with a Senning procedure, the primary difference being that the Mustard uses a graft made of Dacron or pericardium, while the Senning uses native heart tissue.
Helen Brooke Taussig (May 24, 1898 – May 20, 1986) was an American cardiologist, working in Baltimore and Boston, who founded the field of pediatric cardiology.She is credited with developing the concept for a procedure that would extend the lives of children born with Tetralogy of Fallot (the most common cause of blue baby syndrome).
MBTS shunt provides connection from the pulmonary artery to brachiocephalic artery or subclavian artery, while the RVPA conduit provides connection from right ventricle to pulmonary artery. [21] [5] Blalock-Taussig Shunt, a Gore-Tex conduit (a kind of plastic tubing) is used to connect the subclavian artery to the pulmonary artery. In this case ...
Boise could also have safety Alexander Teubner back. Teubner is sixth on the team in tackles with 49 despite missing the last three games. Coach Spencer Danielson said Teubner is back practicing ...
Vivien Theodore Thomas (August 29, 1910 [1] – November 26, 1985) [2] was an American laboratory supervisor who, in the 1940s, played a major role in developing a procedure now called the Blalock–Thomas–Taussig shunt used to treat blue baby syndrome (now known as cyanotic heart disease) along with surgeon Alfred Blalock and cardiologist Helen B. Taussig. [3]